The rationale for radical cystectomy as primary therapy for T4 bladder cancer

World Journal of Urology

Volumn 25, Issue 4, 2007, Pages 401-405

  Nagele, Udo ^a   Anastasiadis, Aristotelis G ^a   Merseburger, Axel S ^a   Corvin, Stefan ^a   Hennenlotter, Jörg ^a   Adam, Melanie ^a   Sievert, Karl Dietrich ^a   Stenzl, Arnulf ^a   Kuczyk, Markus A ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Bladder cancer; Cystectomy; Survival; Treatment

Indexed keywords

AGED; ARTICLE; BLADDER TUMOR; CANCER STAGING; CYSTECTOMY; FOLLOW UP; GERMANY; HUMAN; METHODOLOGY; MIDDLE AGED; MORTALITY; PATHOLOGY; RETROSPECTIVE STUDY; SURVIVAL RATE; TIME; TREATMENT OUTCOME;

AGED; CYSTECTOMY; FOLLOW-UP STUDIES; GERMANY; HUMANS; MIDDLE AGED; NEOPLASM STAGING; RETROSPECTIVE STUDIES; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME; URINARY BLADDER NEOPLASMS;

EID: 34548152367     PISSN: 07244983     EISSN: 14338726     Source Type: Journal    
DOI: 10.1007/s00345-007-0172-9     Document Type: Article

References (19)

1. Skinner DG, Stein JP, Lieskovsky G, Skinner EC, Boyd SD, Figueroa A et al (1998) 25-year experience in the management of invasive bladder cancer by radical cystectomy. Eur Urol 33(Suppl 4):25-26
2. Figueroa AJ, Stein JP, Dickinson M, Skinner EC, Thangathurai D, Mikhail MS et al (1998) Radical cystectomy for elderly patients with bladder carcinoma: An updated experience with 404 patients. Cancer 83(1):141-147
3. Zebic N, Weinknecht S, Kroepfl D (2005) Radical cystectomy in patients aged > or = 75 years: An updated review of patients treated with curative and palliative intent. BJU Int 95(9):1211-1214
4. Rodel C, Grabenbauer GG, Kuhn R, Papadopoulos T, Dunst J, Meyer M et al (2002) Combined-modality treatment and selective organ preservation in invasive bladder cancer: Long-term results. J Clin Oncol 20(14):3061-3071
5. Dunst J, Diestelhorst A, Kuhn R, Muller AC, Scholz HJ, Fornara P (2005) Organ-sparing treatment in muscle-invasive bladder cancer. Strahlenther Onkol 181(10):632-637
6. Arias F, Dominguez MA, Martinez E, Illarramendi JJ, Miquelez S, Pascual I et al (2000) Chemoradiotherapy for muscle invading bladder carcinoma. Final report of a single institutional organ-sparing program. Int J Radiat Oncol Biol Phys 47(2):373-378
7. Chen WC, Liaw CC, Chuang CK, Chen MF, Chen CS, Lin PY, et al. (2003) Concurrent cisplatin, 5-fluorouracil, leucovorin, and radiotherapy for invasive bladder cancer. Int J Radiat Oncol Biol Phys 56(3):726-733
8. Tekin A, Aki FT, Ozen H (2001) Radical cystectomy versus alternative treatments for muscle-confined bladder cancer. Int Urol Nephrol 33(2):357-362
9. Wilson JR, Urwin GH, Stower MJ (2005) The role of percutaneous nephrostomy in malignant ureteric obstruction. Ann R Coll Surg Engl 87(1):21-24
10. Lodde M, Palermo S, Comploj E, Signorello D, Mian C, Lusuardi L et al (2005) Four years experience in bladder preserving management for muscle invasive bladder cancer. Eur Urol 47(6):773-778; discussion 778-9
11. George L, Bladou F, Bardou VJ, Gravis G, Tallet A, Alzieu C et al (2004) Clinical outcome in patients with locally advanced bladder carcinoma treated with conservative multimodality therapy. Urology 64(3):488-493
12. Douglas RM, Kaufman DS, Zietman AL, Althausen AF, Heney NM, Shipley WU (1996) Conservative surgery, patient selection, and chemoradiation as organ-preserving treatment for muscle-invading bladder cancer. Semin Oncol 23(5):614-620
13. Mantadakis E, Panagiotidis C, Delakas D, Samonis G (2003) Symptomatic relief of patients with advanced bladder carcinoma after regional intra-arterial chemotherapy. Anticancer Res 23(6D):5143-5147
14. Hussain MH, Glass TR, Forman J, Sakr W, Smith DC, Al-Sarraf M et al (2001) Combination cisplatin, 5-fluorouracil and radiation therapy for locally advanced unresectable or medically unfit bladder cancer cases: A Southwest Oncology Group Study. J Urol 165(1):56-60; discussion 60-1
15. Grossman HB, Natale RB, Tangen CM, Speights VO, Vogelzang NJ, Trump DL, deVere White RW, Sarosdy MF, Wood DP, Raghavan D, Crawford ED (2003) Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer. N Engl J Med 349:859-866
16. Hautmann RE (1998) Complications and results after cystectomy in male and female patients with locally invasive bladder cancer. Eur Urol 33(Suppl 4):23-24
17. Teramukai S, Nishiyama H, Matsui Y, Ogawa O, Fukushima M (2006) Evaluation for surrogacy of end points by using data from observational studies: Tumor downstaging for evaluating neoadjuvant chemotherapy in invasive bladder cancer. Clin Cancer Res 12(1):139-143
18. Cam K, Yildirim A, Ozveri H, Turkeri L, Akdas A (2002) The efficacy of neoadjuvant chemotherapy in invasive bladder cancer. Int Urol Nephrol 33(1):49-52
19. Nieuwenhuijzen JA, Horenblas S, Meinhardt W, van Tinteren H, Moonen LM (2004) Salvage cystectomy after failure of interstitial radiotherapy and external beam radiotherapy for bladder cancer. BJU Int 94(6):793-797